Delivery Order SPE2DE24DA017-SPE2D625F12ED

Award Date 1/3/25
Potential Completion Date 1/8/25
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures based in Naples, Florida. The $8,943.00 fixed-price delivery order is for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used for platelet-rich plasma (PRP) therapy. The contract has an ultimate completion date of November 4, 2024 and does not utilize any set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain, a component of the U.S. Department of Defense, to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $12,546.60 fixed-price delivery order contract is for the provision of the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used for the preparation of Platelet-Rich Plasma (PRP). The contract has an ultimate completion date of November 13,...
The U.S. government's Defense Logistics Agency (DLA) has awarded a delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,577.20, is for the provision of the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used in orthopedic procedures. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $471,048,172.66, which allows VA medical centers nationwide to acquire...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, for the supply of ARTHREX ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY). The contract has a ceiling value of $2,587.12 and is a fixed-price with economic price adjustment type. The contract is not designated as a set-aside. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,577.20 fixed-price delivery order is for the supply of Arthrex's ANGEL PRP (Platelet-Rich Plasma) Kits, which are used in orthopedic procedures. This contract is not designated as a set-aside. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant single-award Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $11,447.04 Delivery Order contract is for the procurement of Arthrex's ANGEL PRP (Platelet-Rich Plasma) Kit, a specialized surgical device used to concentrate and deliver autologous platelet-rich plasma for various orthopedic applications. Arthrex holds a significant $471,048,172.66 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $14,308.80, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is a Delivery Order for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device used in platelet-rich plasma (PRP) procedures. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of November 4, 2024. Arthrex, a...
This federal contract award is for the delivery of Arthrex ANGEL PRP (Platelet-Rich Plasma) Kits to the Medical Supply Chain of the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. The fixed-price delivery order has a ceiling value of $1,788.60 and an ultimate completion date of October 31, 2024. This award is not designated as a set-aside...
This federal contract award was issued by the Department of Defense's (DoD) Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,577.20 fixed-price delivery order is for the supply of ARTHREX ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY) and has an ultimate completion date of November 1, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,788.60, is for the delivery of Arthrex's ANGEL PRP (Platelet-Rich Plasma) KIT (US TRAY) and has a completion date of October 24, 2024. This delivery order contract is a fixed-price with economic price adjustment arrangement and is not designated as a set-aside contract. Arthrex, a...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F12ED
    Delivery Order

The U.S. government's Defense Logistics Agency (DLA) awarded a $2,861.76 fixed-price delivery order to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures based in Naples, Florida. The contract is for the ARTHREX ANGEL PRP KIT (US TRAY), a specialized medical device for platelet-rich plasma (PRP) therapy. This award is part of Arthrex's larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the DLA, which allows VA medical centers nationwide to acquire the company's innovative orthopedic technologies through task orders. Under this IDC, Arthrex provides a wide range of orthopedic products, including surgical implants, arthroscopic instruments, and joint replacement technologies, to support government healthcare systems in meeting the diverse medical needs of veterans and military personnel. The contract award does not have a set-aside designation, indicating Arthrex's strong competitive position in the open federal market.

Generated 4/4/25, 9:47 AM